A Phase 1, Multicenter, Open-Label, Dose Escalation, Dose Expansion and Dose Confirmation Study of BHV-1530 in Adult Participants with Advanced or Metastatic Solid Tumors
Clinical Trial Grant
Awarded By
Biohaven Pharmaceuticals
Start Date
August 25, 2025
End Date
August 24, 2030
Awarded By
Biohaven Pharmaceuticals
Start Date
August 25, 2025
End Date
August 24, 2030